| Code | Description | Claims | Beneficiaries | Total Paid |
| 67028 |
Intravitreal injection of a pharmacologic agent |
989 |
810 |
$13K |
| 92134 |
|
1,249 |
1,150 |
$10K |
| J9035 |
Injection, bevacizumab, 10 mg |
816 |
730 |
$7K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
62 |
61 |
$2K |
| 92235 |
|
28 |
28 |
$889.38 |
| 92250 |
|
28 |
28 |
$218.66 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
805 |
680 |
$0.00 |
| 2022F |
|
85 |
67 |
$0.00 |
| 2026F |
|
85 |
67 |
$0.00 |
| 5010F |
|
83 |
65 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
118 |
103 |
$0.00 |
| 2024F |
|
85 |
67 |
$0.00 |
| 1036F |
|
775 |
650 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
625 |
547 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
285 |
252 |
$0.00 |
| 4177F |
|
45 |
38 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
83 |
65 |
$0.00 |